Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX

Cohen Joshua B received 60,039 Amylyx Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Aug 18, 2026 · Filed Aug 20, 2026

On Aug 18, 2026, Cohen Joshua B (Director, Co-Chief Executive Officer) received 60,039 Amylyx Pharmaceuticals, Inc. shares as an award, leaving 3,643,587 shares. Filed Aug 20, 2026 (Form 4).

Awarded
60,039 shares
Holding after
3,643,587 shares
Trading plan
No
Role
Director, Co-Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 18, 2026Common StockAward60,0393,643,587Direct

Source

View original at SEC

Related